Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Daniel Todt and Stephanie Pfaender.
Daniel Todt
Connection Strength
2.442
Stephanie Pfaender
  1. A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes. iScience. 2021 Aug 20; 24(8):102908.
    View in: PubMed
    Score: 0.240
  2. Antiviral Effect of Budesonide against SARS-CoV-2. Viruses. 2021 07 20; 13(7).
    View in: PubMed
    Score: 0.239
  3. Pasteurization Inactivates SARS-CoV-2-Spiked Breast Milk. Pediatrics. 2021 01; 147(1).
    View in: PubMed
    Score: 0.227
  4. LY6E impairs coronavirus fusion and confers immune control of viral disease. Nat Microbiol. 2020 11; 5(11):1330-1339.
    View in: PubMed
    Score: 0.223
  5. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols. Emerg Infect Dis. 2020 07; 26(7):1592-1595.
    View in: PubMed
    Score: 0.222
  6. Temperature-dependent surface stability of SARS-CoV-2. J Infect. 2020 09; 81(3):452-482.
    View in: PubMed
    Score: 0.221
  7. The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor. Antimicrob Agents Chemother. 2018 11; 62(11).
    View in: PubMed
    Score: 0.198
  8. Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids. Front Microbiol. 2018; 9:504.
    View in: PubMed
    Score: 0.190
  9. Immune protection against reinfection with nonprimate hepacivirus. Proc Natl Acad Sci U S A. 2017 03 21; 114(12):E2430-E2439.
    View in: PubMed
    Score: 0.177
  10. Comparable Environmental Stability and Disinfection Profiles of the Currently Circulating SARS-CoV-2 Variants of Concern B.1.1.7 and B.1.351. J Infect Dis. 2021 08 02; 224(3):420-424.
    View in: PubMed
    Score: 0.060
  11. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay. Clin Microbiol Infect. 2021 Sep; 27(9):1353.e1-1353.e5.
    View in: PubMed
    Score: 0.059
  12. Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2. J Hosp Infect. 2021 Jun; 112:27-30.
    View in: PubMed
    Score: 0.058
  13. Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2021 02 13; 223(3):541.
    View in: PubMed
    Score: 0.058
  14. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476. J Hosp Infect. 2021 May; 111:180-183.
    View in: PubMed
    Score: 0.058
  15. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020 09 14; 222(8):1289-1292.
    View in: PubMed
    Score: 0.056
  16. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes. Vaccines (Basel). 2020 Jul 15; 8(3).
    View in: PubMed
    Score: 0.056
  17. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020 Mar; 104(3):246-251.
    View in: PubMed
    Score: 0.054
  18. Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. J Infect Dis. 2017 03 15; 215(6):902-906.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.